Retinal Vein Occlusion Visual Prognosis and Treatment Criteria

Assesses CRVO and BRVO visual prognosis using BCVA, macular edema on OCT, and ischemia index (nonperfusion on FA/OCTA), with anti-VEGF treatment loading dose criteria.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Assesses CRVO and BRVO visual prognosis using BCVA, macular edema on OCT, and ischemia index (nonperfusion on FA/OCTA), with anti-VEGF treatment loading dose criteria

Each component has a specific meaning:

  • BCVA — The bcva recorded for the patient or scenario being assessed.
  • Macular edema on OCT — The macular edema on oct recorded for the patient or scenario being assessed.
  • Ischemia index — The ischemia index recorded for the patient or scenario being assessed.

Note: Interpret the rvo treatment result against the clinical thresholds and context described above.

How to Use

Enter the BCVA, macular edema on OCT, ischemia index for the patient or scenario you are assessing. Assesses CRVO and BRVO visual prognosis using BCVA, macular edema on OCT, and ischemia index (nonperfusion on FA/OCTA), with anti-VEGF treatment loading dose criteria. Use the rvo treatment result to inform your clinical assessment.

Frequently Asked Questions